** Shares of Phreesia Inc PHR.N down ~6% at $27.6; among
top three pct losers among NYSE-listed stocks trading premarket
** Posts Q4 net loss of $46.45 mln vs $8.42 mln a year
earlier, dragged by higher expenses urn:newsml:reuters.com:*:nBw5XjPQ8a
** Total expenses rise to $104.64 mln from $50.1 mln in the
same period last year
** The medical software developer reports a 39% y/y jump in
revenue to $58 mln
** At three brokerages have cut PT on co's stock, with SVB
Leerink at a Street low of $29
** The magnitude of the guided FY23 EBITDA burn was worse
than we anticipated, JPM says
** 10 of 13 brokerages rate the stock "buy" or higher and 3
"hold"; their median PT is $54 vs $55 a month ago
** Up to Wednesday's close, stock had fallen ~29% YTD
compared with the S&P 500 index's .SPX 4.05% decline
(Reporting by Sohini Podder in Bengaluru)
((sohini.podder@thomsonreuters.com))